In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews ...

Besides the traditional obesity treatments of a healthy diet and exercise, the pharmaceutical industry has played a role in these efforts with the introduction of glucagon-like-peptide-1 (GLP-1) ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, explains how collaboration between compounding pharmacies, drug ...

Despite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ...

Upperton Pharma Solutions, a contract development and manufacturing organization (CDMO), has completed the construction of its new 7,000 square-foot sterile manufacturing facility in Nottingham, UK, 1 ...

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

In a video interview with Pharma Commerce, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, explains how she participated in two key sessions: “Trade 101” and ...

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions. The FDA is set to review the Biologics License Applications (BLAs) for ...

The latest news for pharma industry insiders.

In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, describes how she ...

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area. AstraZeneca will be investing $570 million in ...